{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T04:25:23Z","timestamp":1767155123029},"reference-count":53,"publisher":"Impact Journals, LLC","issue":"14","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,4,4]]},"DOI":"10.18632\/oncotarget.15196","type":"journal-article","created":{"date-parts":[[2017,2,15]],"date-time":"2017-02-15T19:17:50Z","timestamp":1487186270000},"page":"22772-22782","source":"Crossref","is-referenced-by-count":9,"title":["Somatic molecular subtyping of prostate tumors from <i>HOXB13<\/i> G84E carriers"],"prefix":"10.18632","volume":"8","author":[{"given":"Tamara L.","family":"Lotan","sequence":"first","affiliation":[{"name":"Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA"},{"name":"Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alba","family":"Torres","sequence":"additional","affiliation":[{"name":"Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miao","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Pathology the University of Texas MD Anderson Cancer Center, Houston, TX, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey J.","family":"Tosoian","sequence":"additional","affiliation":[{"name":"Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liana B.","family":"Guedes","sequence":"additional","affiliation":[{"name":"Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"Fedor","sequence":"additional","affiliation":[{"name":"Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Hicks","sequence":"additional","affiliation":[{"name":"Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles M.","family":"Ewing","sequence":"additional","affiliation":[{"name":"Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah D.","family":"Isaacs","sequence":"additional","affiliation":[{"name":"Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorhyun","family":"Johng","sequence":"additional","affiliation":[{"name":"Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelo M.","family":"De Marzo","sequence":"additional","affiliation":[{"name":"Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA"},{"name":"Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA"},{"name":"Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William B.","family":"Isaacs","sequence":"additional","affiliation":[{"name":"Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA"},{"name":"Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2017,2,8]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/nrurol.2013.266","article-title":"The genetic epidemiology of prostate cancer and its clinical implications","volume":"11","author":"Kote-Jarai","year":"2014","journal-title":"Nat Rev Urol"},{"key":"2","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1002\/ijc.29949","article-title":"Screening for familial and hereditary prostate cancer","volume":"138","author":"Powell","year":"2016","journal-title":"Int J Cancer"},{"key":"3","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1056\/NEJMoa1110000","article-title":"Germline mutations in HOXB13 and prostate-cancer risk","volume":"366","author":"Gielzak","year":"2012","journal-title":"N Engl J Med"},{"key":"4","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1158\/1055-9965.EPI-12-0495","article-title":"Confirmation of the HOXB13 G84E germline mutation in familial prostate cancer","volume":"21","author":"Smith","year":"2012","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"5","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1093\/jnci\/djs288","article-title":"Association between germline HOXB13 G84E mutation and risk of prostate cancer","volume":"104","author":"Nam","year":"2012","journal-title":"J Natl Cancer Inst"},{"key":"6","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.eururo.2013.03.007","article-title":"Germline homeobox B13 (HOXB13) G84E mutation and prostate cancer risk in European descendants: a meta-analysis of 24,213 cases and 73, 631 controls","volume":"64","author":"Niu","year":"2013","journal-title":"Eur Urol"},{"key":"7","doi-asserted-by":"crossref","first-page":"e54727","DOI":"10.1371\/journal.pone.0054727","article-title":"Population-based estimate of prostate cancer risk for carriers of the HOXB13 missense mutation G84E","volume":"8","author":"Giles","year":"2013","journal-title":"PLoS One"},{"key":"8","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1093\/carcin\/bgt055","article-title":"The G84E mutation of HOXB13 is associated with increased risk for prostate cancer: results from the REDUCE trial","volume":"34","author":"Xu","year":"2013","journal-title":"Carcinogenesis"},{"key":"9","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1002\/pros.22594","article-title":"The G84E mutation in the HOXB13 gene is associated with an increased risk of prostate cancer in Poland","volume":"73","author":"Borkowski","year":"2013","journal-title":"Prostate"},{"key":"10","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/pros.22604","article-title":"HOXB13 mutations in a population-based, case-control study of prostate cancer","volume":"73","author":"Ostrander","year":"2013","journal-title":"Prostate"},{"key":"11","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00439-012-1229-4","article-title":"HOXB13 is a susceptibility gene for prostate cancer: results from the International Consortium for Prostate Cancer Genetics (ICPCG)","volume":"132","author":"Ostrander","year":"2013","journal-title":"Human genetics"},{"key":"12","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1007\/s13277-013-1157-5","article-title":"G84E mutation in HOXB13 is firmly associated with prostate cancer risk: a meta-analysis","volume":"35","author":"Cai","year":"2014","journal-title":"Tumour biology"},{"key":"13","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1242\/dev.00432","article-title":"Hoxb13 is required for normal differentiation and secretory function of the ventral prostate","volume":"130","author":"Capecchi","year":"2003","journal-title":"Development"},{"key":"14","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.molcel.2009.10.020","article-title":"The homeodomain protein HOXB13 regulates the cellular response to androgens","volume":"36","author":"McDonnell","year":"2009","journal-title":"Mol Cell"},{"key":"15","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.cell.2015.10.025","article-title":"The Molecular Taxonomy of Primary Prostate Cancer","volume":"163","author":"Cancer Genome Atlas Research N","year":"2015","journal-title":"Cell"},{"key":"16","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1126\/science.1117679","article-title":"Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer","volume":"310","author":"Shah","year":"2005","journal-title":"Science"},{"key":"17","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1158\/1055-9965.EPI-12-0042","article-title":"The TMPRSS2: ERG rearrangement, ERG expression, and prostate cancer outcomes: a cohort study and meta-analysis","volume":"21","author":"Sesso","year":"2012","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"18","doi-asserted-by":"crossref","first-page":"3396","DOI":"10.1158\/0008-5472.CAN-06-0168","article-title":"TMPRSS2: ETV4 gene fusions define a third molecular subtype of prostate cancer","volume":"66","author":"Chinnaiyan","year":"2006","journal-title":"Cancer Res"},{"key":"19","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/pros.21265","article-title":"TMPRSS2-ERG gene fusion prevalence and class are significantly different in prostate cancer of Caucasian, African-American and Japanese patients","volume":"71","author":"Zhou","year":"2011","journal-title":"Prostate"},{"key":"20","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.urology.2012.07.001","article-title":"Differences in frequency of ERG oncoprotein expression between index tumors of Caucasian and African American patients with prostate cancer","volume":"80","author":"Srivastava","year":"2012","journal-title":"Urology"},{"key":"21","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.eururo.2015.04.033","article-title":"Characterization of 1577 primary prostate cancers reveals novel biological and clinicopathologic insights into molecular subtypes","volume":"68","author":"Schaeffer","year":"2015","journal-title":"Eur Urol"},{"key":"22","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.eururo.2016.07.026","article-title":"Prevalence and Prognostic Significance of PTEN Loss in African-American and European-American Men Undergoing Radical Prostatectomy","volume":"71","author":"Trock","year":"2017","journal-title":"Eur Urol"},{"key":"23","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.juro.2016.09.084","article-title":"PTEN Loss in Gleason Score 3 + 4 = 7 Prostate Biopsies is Associated with Non-Organ Confined Disease at Radical Prostatectomy","volume":"197","author":"Guedes","year":"2017","journal-title":"J Urol"},{"key":"24","doi-asserted-by":"crossref","first-page":"4925","DOI":"10.1158\/1078-0432.CCR-13-2265","article-title":"Evidence for Molecular Differences in Prostate Cancer between African American and Caucasian Men","volume":"20","author":"Robinson","year":"2014","journal-title":"Clin Cancer Res"},{"key":"25","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/ng0497-356","article-title":"Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers","volume":"15","author":"Swedlund","year":"1997","journal-title":"Nature genetics"},{"key":"26","doi-asserted-by":"crossref","first-page":"6563","DOI":"10.1158\/1078-0432.CCR-11-1244","article-title":"PTEN protein loss by immunostaining: analytic validation and prognostic indicator for a high risk surgical cohort of prostate cancer patients","volume":"17","author":"Isaacs","year":"2011","journal-title":"Clin Cancer Res"},{"key":"27","first-page":"108","article-title":"A Prospective Investigation of PTEN Loss and ERG Expression in Lethal Prostate Cancer","author":"Finn","year":"2016","journal-title":"J Natl Cancer Inst"},{"key":"28","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/modpathol.2014.85","article-title":"PTEN loss is associated with upgrading of prostate cancer from biopsy to radical prostatectomy","volume":"28","author":"Berman","year":"2015","journal-title":"Mod Pathol"},{"key":"29","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.euf.2015.07.005","article-title":"PTEN Loss as Determined by Clinical-grade Immunohistochemistry Assay Is Associated with Worse Recurrence-free Survival in Prostate Cancer","volume":"2","author":"Lin","year":"2016","journal-title":"Eur Urol Focus"},{"key":"30","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/ng.371","article-title":"Cooperativity of TMPRSS2-ERG with PI3-kinase pathway activation in prostate oncogenesis","volume":"41","author":"Sawyers","year":"2009","journal-title":"Nat Genet"},{"key":"31","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1038\/modpathol.2008.96","article-title":"Absence of TMPRSS2: ERG fusions and PTEN losses in prostate cancer is associated with a favorable outcome","volume":"21","author":"Squire","year":"2008","journal-title":"Mod Pathol"},{"key":"32","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/pcan.2013.8","article-title":"Assessing the order of critical alterations in prostate cancer development and progression by IHC: further evidence that PTEN loss occurs subsequent to ERG gene fusion","volume":"16","author":"De Marzo","year":"2013","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"33","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/j.1464-410X.2010.09470.x","article-title":"PTEN genomic deletion is an early event associated with ERG gene rearrangements in prostate cancer","volume":"107","author":"Squire","year":"2011","journal-title":"BJU international"},{"key":"34","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1111\/bju.12522","article-title":"Prevalence of the HOXB13 G84E prostate cancer risk allele in men treated with radical prostatectomy","volume":"113","author":"Cooney","year":"2014","journal-title":"BJU Int"},{"key":"35","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1093\/annonc\/mdv004","article-title":"Prevalence of the HOXB13 G84E germline mutation in British men and correlation with prostate cancer risk, tumour characteristics and clinical outcomes","volume":"26","author":"Neal","year":"2015","journal-title":"Ann Oncol"},{"key":"36","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1111\/bju.13416","article-title":"Prevalence of the HOXB13 G84E mutation in Danish men undergoing radical prostatectomy and its correlations with prostate cancer risk and aggressiveness","volume":"118","author":"Sorensen","year":"2016","journal-title":"BJU Int"},{"key":"37","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1097\/PAS.0000000000000090","article-title":"HOXB13 G84E-related familial prostate cancers: a clinical, histologic, and molecular survey","volume":"38","author":"Tomlins","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"38","first-page":"e32","article-title":"Novel RNA hybridization method for the in situ detection of ETV1, ETV4, and ETV5 gene fusions in prostate cancer. Appl Immunohistochem","volume":"22","author":"Palanisamy","year":"2014","journal-title":"Mol Morphol"},{"key":"39","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.ccr.2008.04.016","article-title":"The role of SPINK1 in ETS rearrangement-negative prostate cancers","volume":"13","author":"Andren","year":"2008","journal-title":"Cancer cell"},{"key":"40","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/ng.613","article-title":"Androgen-induced TOP2B-mediated double-strand breaks and prostate cancer gene rearrangements","volume":"42","author":"De Marzo","year":"2010","journal-title":"Nat Genet"},{"key":"41","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ajpath.2012.04.026","article-title":"Genomic deletion of PTEN is associated with tumor progression and early PSA recurrence in ERG fusion-positive and fusion-negative prostate cancer","volume":"181","author":"Sirma","year":"2012","journal-title":"Am J Pathol"},{"key":"42","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/sj.bjc.6605554","article-title":"Molecular characterisation of ERG, ETV1 and PTEN gene loci identifies patients at low and high risk of death from prostate cancer","volume":"102","author":"Gerald","year":"2010","journal-title":"Br J Cancer"},{"key":"43","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/his.12153","article-title":"TMPRSS2-ERG rearrangement in dominant anterior prostatic tumours: incidence and correlation with ERG immunohistochemistry","volume":"63","author":"Fine","year":"2013","journal-title":"Histopathology"},{"key":"44","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.eururo.2015.09.031","article-title":"Racial Variations in Prostate Cancer Molecular Subtypes and Androgen Receptor Signaling Reflect Anatomic Tumor Location","volume":"70","author":"Schaeffer","year":"2016","journal-title":"Eur Urol"},{"key":"45","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/PAS.0b013e31812f7b27","article-title":"Anterior-predominant prostatic tumors: zone of origin and pathologic outcomes at radical prostatectomy","volume":"32","author":"Fine","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"46","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/modpathol.2016.88","article-title":"Analytic validation of a clinical-grade PTEN immunohistochemistry assay in prostate cancer by comparison with PTEN FISH","volume":"29","author":"Simko","year":"2016","journal-title":"Mod Pathol"},{"key":"47","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1097\/PAS.0b013e31821e8761","article-title":"Immunohistochemistry for ERG expression as a surrogate for TMPRSS2-ERG fusion detection in prostatic adenocarcinomas","volume":"35","author":"Netto","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"48","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/pros.23138","article-title":"Statin use and risk of disease recurrence and death after radical prostatectomy","volume":"76","author":"Murtola","year":"2016","journal-title":"Prostate"},{"key":"49","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1158\/1055-9965.EPI-13-0333-T","article-title":"Loss of PTEN is associated with aggressive behavior in ERG-positive prostate cancer","volume":"22","author":"Tammela","year":"2013","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"50","first-page":"136","article-title":"A comparative study of ERG status assessment on DNA, mRNA, and protein levels using unique samples from a Swedish biopsy cohort. Appl Immunohistochem","volume":"22","author":"Rubin","year":"2014","journal-title":"Mol Morphol"},{"key":"51","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/path.3023","article-title":"TP53 mutations in serous tubal intraepithelial carcinoma and concurrent pelvic high-grade serous carcinoma\u2014evidence supporting the clonal relationship of the two lesions","volume":"226","author":"Shih","year":"2012","journal-title":"J Pathol"},{"key":"52","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/path.4186","article-title":"Nucleotide resolution analysis of TMPRSS2 and ERG rearrangements in prostate cancer","volume":"230","author":"Yegnasubramanian","year":"2013","journal-title":"J Pathol"},{"key":"53","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/nature06024","article-title":"Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer","volume":"448","author":"Montie","year":"2007","journal-title":"Nature"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.15196","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,10]],"date-time":"2020-05-10T18:09:13Z","timestamp":1589134153000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.15196"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,8]]},"references-count":53,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2017,4,4]]}},"alternative-id":["15196","28186998"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.15196","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,8]]}}}